Citi Pharma Limited (PSX:CPHL)

Pakistan flag Pakistan · Delayed Price · Currency is PKR
87.07
-1.50 (-1.69%)
At close: Mar 27, 2025
273.53%
Market Cap 19.89B
Revenue (ttm) 13.19B
Net Income (ttm) 821.88M
Shares Out 228.46M
EPS (ttm) 3.60
PE Ratio 24.20
Forward PE n/a
Dividend 3.25 (3.73%)
Ex-Dividend Date Oct 17, 2024
Volume 1,310,940
Average Volume 4,213,768
Open 88.85
Previous Close 88.57
Day's Range 86.89 - 89.20
52-Week Range 23.00 - 109.30
Beta 0.59
RSI 40.57
Earnings Date Apr 29, 2025

About Citi Pharma

Citi Pharma Limited engages in the manufacture and sale of pharmaceutical, medical chemical, and botanical products in Pakistan. Citi Pharma Limited was incorporated in 2012 and is headquartered in Lahore, Pakistan. [Read more]

Industry Pharmaceuticals
Sector Healthcare
Founded 2012
Employees 519
Stock Exchange Pakistan Stock Exchange
Ticker Symbol CPHL
Full Company Profile

Financial Performance

In 2024, Citi Pharma's revenue was 12.41 billion, an increase of 0.10% compared to the previous year's 12.40 billion. Earnings were 833.46 million, an increase of 26.67%.

Financial Statements

News

There is no news available yet.